NTUS earnings call for the period ending September 30, 2019.
News & Analysis: Natus Medical
It wasn't just lower-than-expected earnings that hurt the medical device company.
The company's softer-than-expected outlook wasn't what investors wanted to see.
It seems investors are excited by the lack of bad news.
A sales growth warning rattled investors last month.
2017 ended with a bust, and it won't be a quick turnaround for the medical-device maker
A bottom-line contraction in the first quarter isn't what the market wanted to hear.
It was a rough first quarter for the medical device and services company.
The medical equipment maker makes an acquisition to spur growth, but investors are focused on the current quarter.
Preliminary first-quarter revenue at the medical-device maker was lower than previous guidance.